Hca Healthcare, Inc. · NYSE:HCA
Hca Healthcare — Investor Presentation (2019)
17 slides from Hca Healthcare's investor presentation, 2019
Slide 1: Investor Update Q3 2019
Investor Update Q3 2019 Medical City Dallas HCA Healthcare”
Slide 2: Forward Looking Statements and Non-GAAP Financial Measures
Forward Looking Statements and Non-GAAP Financial Measures This presentation may contain certain forward-looking statements provided by Company management. These statements are intended to be covered by the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looki
Slide 3: Diversified Mix of Facilities, Services, and Settings
Diversified Mix of Facilities, Services, and Settings Acute Ambulatory Access Physicians Care Services Centers 184 125 164 ~1,329 Hospitals ASCs Urgent Care Centers Physician Clinics 48.6k 20 100 ~38k Licensed Beds GI Centers FSERs Active Medical Staff Figures as of September 30, 2019 3 Investor Upd
Slide 4: Strategic Guiding Principles
Strategic Guiding Principles Committed to industry Industry leading efficiency leading quality & service Growth through patient Development of “ Be the provider system of choice for patients and & physician relationships future leaders physicians by leveraging the scale and capabilities of HCA Healt
Slide 5: Strong Market Presence
Strong Market Presence 25.3% Salt Lake Denver Northern Kansas Virginia City San Jose Wichita SWVA Las Nashville Richmond Vegas HCA Healthcare Southern California market share ranks Western North Myrtle Carolina 1st or 2nd in 27 of El Paso Beach Austin 37 studied markets DFW Charleston HCA Healthcare
Slide 6: Consistent Top Line Growth
Consistent Top Line Growth Admissions Equivalent Admissions Revenues 5 year CAGR1 2.8% 5 year CAGR1 3.8% 5 year CAGR1 6.4% 20182 2.00M 20182 3.42M 20182 $46.68B 2019 over PY3 4.6% 2019 over PY3 6.2% 2019 over PY3 9.9% Surgeries Emergency Room Visits 5 year CAGR1 1.8% 5 year CAGR1 4.7% 20182 1.52M 20
Slide 7: Adjusted EBITDA & EPS Growth
Adjusted EBITDA & EPS Growth $9.77 $8.9B $10 $9.0 Adjusted EBITDA in Billions $8.8 $9 $8.6 4.2% 20.7% $8 Diluted EPS* 3 YR $8.4 Adj. CAGR $7 Diluted $8.2 EBITDA EPS $5.56 $6 $8.0 $7.9B $7.8 $5 $7.6 $4 2015 2016 2017 2018 2015 2016 2017 2018 • Q3 2019 - for the nine months ended September 30, 2019, A
Slide 8: Deploying a Balanced Allocation of Capital
Deploying a Balanced Allocation of Capital Investing in Growth Delivering Shareholder Value $21.9B $3.2B Capital Expenditures Special Dividends $8.2B Cash Flow from $901M Acquisition Capital Operations Quarterly Dividends* $43.0B $13.2B Share Repurchases Cash Flows provided by Operations and primary
Slide 9: Provider System of Choice
Provider System of Operational Excellence Choice Coordination Across Access and Continuum Convenience Local Sustainable Growth Strong Comprehensive Physician Service Relationships Lines 9 Investor Update
Slide 10: Comprehensive Access Across the Continuum
Comprehensive Access Across the Continuum 3 Nashville, TN Market Hospitals 10 5 Imaging Centers 21 Ambulatory Surgery Centers 6 3 Health Parks 9 2 7 TriStar Medical Group Locations 68 2 5 Freestanding ERs 4 3 CareNow Urgent Care Centers 15 Transfer Center 1 Figures as of September 2019 10 Investor U
Slide 11: Sources of Differentiation
Sources of Differentiation Capital Improve Our Business Drive Growth Innovation Speed to Market Support Execution Economies of Scale 11 Investor Update
Slide 12: Annual Capital Investment
Committed to Ensuring Annual Capital Investment Capacity and Access $30.1B invested since 2011** the 2011 IPO 2012 2013 2019 2014 2015 Pipeline* 2016 2017 2018 1,111 Sept. 2019 YTD $2.88 $1.59 Inpatient Beds $0.0 $0.5 $1.0 $1.5 $2.0 $2.5 $3.0 $3.5 $4.0 $4.5 $5.0 In Billions PP&E Acquisition * Projec
Slide 13: Driving Value for Key Stakeholders
Driving Value for Key Stakeholders Patients Physicians Employees Payers Shareholders Safe Clinical Compensation Comprehensive Earnings Growth Capabilities and Benefits Network of Access High Quality Points and Service Lines Return on Capital Efficient Place Training and Compassionate to Practice Dev
Slide 14: Advancing the Patient Experience
Advancing Strong Leadership the Patient Experience Partnering with Patient Engaged Physicians Experience Employees Big Data/Technology 14 Investor Update
Slide 15: Learning and Improving at Scale
Learning and Improving at Scale Improved Care at the Bedside Improved Care Everywhere SPOT* & Surviving Sepsis Program REDUCE MRSA • SPOT helps detect sepsis ~6 hours earlier than clinicians Care Informs Care • Improved worldwide best practices for • HCA 2019 Red Hat “Innovator of the Year” for SPOT
Slide 16: Partnering with Physicians
Partnering with Physicians VOICE PHYSICIAN ENGAGEMENT TIME GROWTH CLINICAL CAPABILITIES 16 Investor Update
Slide 17: HCA's Competitive Advantage
HCA’s Competitive Advantage Experienced Leadership Diversified Strong Portfolio Operating Culture Financial Scale Strength 17 Investor Update